Picture EBD Group BioPharm America 2019 Boston September 600x60px

News > All

Total search results: 9789 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 24 25 26 ... 96 97 98  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Kite Pharma, Inc.. (1/5/17). "Press Release: Kite Pharma Enhances Commercial Expertise with the Appointment of Ian T. Clark to Its Board of Directors". Santa Monica, CA. 2017-01-05
Bicycle Therapeutics Ltd.. (1/5/17). "Press Release: Bicycle Therapeutics Appoints Nicholas Keen, Ph.D., as Chief Scientific Officer". Cambridge, MA & Cambridge. 2017-01-05
Xigen S.A.. (1/5/17). "Press Release: Xigen’s Brimapitide, an Innovative JNK Inhibitor, Delivers Positive Phase II Results in Inflammatory Eye Disease". Geneva. 2017-01-05
Valneva S.E.. (1/5/17). "Press Release: Valneva Announces a New Research License Agreement with MSD Animal Health for the Development of Vaccines in the EB66 Cell Line". Lyon. 2017-01-05
HepaRegenix GmbH. (1/5/17). "Press Release: HepaRegenix GmbH Raises EUR9 million in a Series A Financing to Develop Kinase Inhibitors for the Treatment of Acute and Chronic Liver Diseases". Tübingen. 2017-01-05
Phenex Pharmaceuticals AG. (1/5/17). "Press Release: Phenex Receives 100 M USD Milestone Payment from Gilead". Ludwigshafen. 2017-01-05
IDT Biologika GmbH. (1/5/17). "Press Release: IDT Biologika Acquires Ridgeway Biologicals Ltd". Dessau & Compton. 2017-01-05
MorphoSys AG. (1/5/17). "Press Release: Dr. Malte Peters to Become New Chief Development Officer of MorphoSys AG". Planegg. 2017-01-05
Pieris Pharmaceuticals, Inc.. (1/5/17). "Press Release: Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance". Boston, MA & Suresnes. 2017-01-05
Tecan Group Ltd.. (1/5/17). "Press Release: Tecan to Present at J.P. Morgan Healthcare Conference". Männedorf. 2017-01-05
Bruker Corporation. (1/4/17). "Press Release: Bruker Announces Acquisition of CMO InVivo Biotech to Expand Molecular Biology, Microbiology and Pathology Consumables and Assay Business". Berlin. 2017-01-04
Bruker Corporation. (1/4/17). "Press Release: Bruker Announces Acquisition of SCiLS GmbH to Advance MALDI Imaging Software Solutions for Life Science, Pharma and Pathology Research Applications". Bremen. 2017-01-04
AiCuris Anti-infective Cures GmbH. (1/4/17). "Press Release: AiCuris Initiates Clinical Development of AIC499, a Novel Resistance-Breaking Antibiotic against a Broad Range of MDR Gram-Negative Bacteria". Wuppertal. 2017-01-04
Affimed N.V.. (1/4/17). "Press Release: Affimed and MD Anderson Announce Clinical Immuno-Oncology Development Collaboration". Heidelberg & Houston, TX. 2017-01-04
Noxxon Pharma N.V.. (1/4/17). "Press Release: Noxxon Pharma Licenses and Assigns Preclinical Spiegelmer Programs to Aptarion. Noxxon Continues Transition to Clinical Oncology Company". Berlin. 2017-01-04
Merck KGaA. (1/4/17). "Press Release: Merck Acquires BioControl to Strengthen Position in Food Safety Testing". Darmstadt. 2017-01-04
Novimmune S.A.. (1/4/17). "Press Release: Novimmune Grants Tiziana an Exclusive License to NI-1201, an anti-IL-6R Monoclonal Antibody for the Treatment of Autoimmune and Inflammatory Diseases". Geneva. 2017-01-04
Innate Pharma S.A.. (1/4/17). "Press Release: Upcoming Investor Conferences". Marseille. 2017-01-04
InflaRx GmbH. (1/4/17). "Press Release: InflaRx Initiates Exploratory Phase II Trial with IFX-1, a First-in-class Anti-complement C5a Antibody, in Patients with Hidradenitis Suppurativa". Jena. 2017-01-04
Rubius Therapeutics, Inc.. (1/4/17). "Press Release: Rubius Therapeutics Announces Appointment of Top Leadership. Company Taps Industry Leaders Epstein and Straight Nissen to Advance Potential Life Saving Technology Platform". Cambridge, MA. 2017-01-04
Juno Therapeutics, Inc.. (1/3/17). "Press Release: Juno Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference". Seattle, WA. 2017-01-03
MorphoSys AG. (1/3/17). "Press Release: MorphoSys to Present at Upcoming Investor Conferences". Planegg. 2017-01-03
SGS S.A.. (1/3/17). "Press Release: SGS Acquires Laboratoire LCA, Morocco". 2017-01-03
Sanofi S.A.. (1/2/17). "Press Release: Sanofi and Boehringer Ingelheim Confirm Closing of Business Swap on January 1st 2017". Paris & Ingelheim. 2017-01-02
Sanofi S.A.. (1/2/17). "Press Release: Sanofi Pasteur and MSD End Joint Vaccines Business in Europe". Paris. 2017-01-02
CureVac AG. (12/28/16). "Press Release: CureVac to Present at the J.P. Morgan 35th Annual Healthcare Conference 2017". Tübingen. 2016-12-28
PerkinElmer, Inc.. (12/22/16). "Press Release: PerkinElmer to Sell Medical Imaging Business to Varian Medical Systems". Waltham, MA. 2016-12-22
SGS S.A.. (12/21/16). "Press Release: SGS Acquires Laagrima, Morocco". 2016-12-21
Bruker Corporation. (12/21/16). "Press Release: Bruker Delivering 300 Hand-held Chemical Detectors to German BBK". Leipzig. 2016-12-21
Actelion Ltd.. (12/21/16). "Press Release: Actelion and Johnson & Johnson Enter into Exclusive Discussions". Allschwil. 2016-12-21
Bayer AG. (12/21/16). "Press Release: Bayer Develops Companion Diagnostic Test for Cancer Patients Together with Leica Biosystems [Not intended for U.S. and UK Media]". Leverkusen. 2016-12-21
Merck KGaA. (12/21/16). "Press Release: Metformin Products, including Glucophage Approved for Type 2 Diabetes Patients with Moderate Renal Impairment in Europe [This release is not intended for US- and UK-based media]". Darmstadt. 2016-12-21
Sygnis AG. (12/21/16). "Press Release: Sygnis AG Acquires Profitable US Life Sciences Tools Company C.B.S. Scientific for US $0.9 Million in Cash and Shares". Madrid & Heidelberg. 2016-12-21
Mologen AG. (12/21/16). "Press Release: Public Rights Offering of Convertible Bonds with Purchase Guarantee by Major Shareholder. Issue volume €4.99 million, Maturity of 8 Years [Not for United States, Australia, Canada or Japan, et al.]". Berlin. 2016-12-21
Pharnext S.A.. (12/20/16). "Press Release: Pharnext Completes Patient Enrollment in International Pivotal Phase 3 Trial of PXT3003 for Charcot-Marie-Tooth Disease Type 1A". Paris. 2016-12-20
Mundipharma International Ltd.. (12/20/16). "Press Release: CHMP Announces Positive Opinion for Biosimilar Rituximab Truxima and Mundipharma Has Secured Distribution Rights". Cambridge. 2016-12-20
Protagen AG. (12/20/16). "Press Release: Protagen AG Successfully Joined Forces with Novartis to Support Clinical Development of a Novel Compound in an Autoimmune Indication". 2016-12-20
SGS S.A.. (12/19/16). "Press Release: SGS Acquires Control of C-Labs SA, Switzerland". 2016-12-19
Novartis AG. (12/16/16). "Press Release: Novartis Bolsters Innovative Dermatology Portfolio through Acquisition of Ziarco Group Limited". Basel. 2016-12-16
ERS Genomics Ltd.. (12/16/16). "Press Release: CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Global Agreement on the Foundational Intellectual Property for CRISPR/Cas9 Gene Editing Technology". Basel, et al.. 2016-12-16
Bruker Corporation. (12/16/16). "Press Release: Bruker Announces Acquisition of Active Spectrum Micro-ESR Business". Billerica, MA. 2016-12-16
Merck KGaA. (12/16/16). "Press Release: Merck and the European Space Agency Extend Collaboration to Foster Innovation, Digitalization". Darmstadt. 2016-12-16
Bluebird Bio, Inc.. (12/15/16). "Press Release: Bluebird Bio and Apceth Biopharma Establish Commercial Drug Product Manufacturing Agreement". Cambridge, MA & Munich. 2016-12-15
Evotec AG. (12/15/16). "Press Release: Evotec Completes Acquisition of Cyprotex plc". Hamburg. 2016-12-15
Evotec AG. (12/15/16). "Press Release: Evotec and Celgene Enter into Drug Discovery Collaboration for Neurodegenerative Diseases". Hamburg. 2016-12-15
Valneva S.E.. (12/15/16). "Press Release: Valneva Confirms Closing of Private Placement in Connection with €15.2m Investment by MVM Life Science Partners". Lyon. 2016-12-15
Noxxon Pharma N.V.. (12/15/16). "Press Release: Noxxon Pharma Signs Clinical Immuno-oncology Collaboration Agreement with MSD to Study NOX-A12 Combined with Keytruda (pembrolizumab) in Pancreatic and Colorectal Cancer". Berlin. 2016-12-15
Lonza Group Ltd.. (12/15/16). "Press Release: Lonza to Acquire Capsugel to Create Leading Integrated Solutions Provider to the Global Pharma and Consumer Healthcare Industries". Basel & Morristown, NJ. 2016-12-15
Univercells S.A.. (12/15/16). "Press Release: Univercells Receives $12 Million Grant to Develop Breakthrough Vaccine Manufacturing Platform". Brussels. 2016-12-15
Acousia Therapeutics GmbH. (12/14/16). "Press Release: Acousia Therapeutics Receives EUR 2.5 Million to Develop Innovative Therapy to Treat and Prevent Sensorineural Hearing Loss". Tübingen. 2016-12-14
Tecan Group Ltd.. (12/14/16). "Press Release: Tecan Announces Change in Management Board". Männedorf. 2016-12-14
High-Tech Gründerfonds Management GmbH. (12/14/16). "Press Release: Chinese Biotech Investor Viroad Takes Over Gilupi". 2016-12-14
Amcure GmbH. (12/14/16). "Press Release: Amcure Raises €6 Million in Series B Financing and Expands Advisory Board". Eggenstein-Leopoldshafen. 2016-12-14
AMSilk GmbH. (12/14/16). "Press Release: Biosteel Fibers from AMSilk Receive Certification for product Safety and Confirmation of Biological Degradability". Planegg. 2016-12-14
Genome Diagnostics B.V. (GenDx). (12/13/16). "Press Release: GenDx Signs Reseller Agreement with Illumina". Utrecht. 2016-12-13
Bayer AG. (12/13/16). "Press Release: Monsanto Shareowners Approve Merger with Bayer". St. Louis, MO. 2016-12-13
MorphoSys AG. (12/13/16). "Press Release: MorphoSys Starts Phase 2 Trial of MOR208 in Combination with Idelalisib in Patients with Relapsed or Refractory CLL or SLL Previously Treated with a BTK Inhibitor". 2016-12-13
Curetis N.V.. (12/13/16). "Press Release: Curetis Acquires Real-Time qPCR Platform from Carpegen and Systec". Amsterdam & Holzgerlingen. 2016-12-13
Protagen AG. (12/13/16). "Press Release: Protagen Launches NavigAID Assay to Support Clinical Drug Development for Autoimmune Diseases". 2016-12-13
Carpegen GmbH. (12/13/16). "Press Release: Curetis Acquires Real-Time qPCR Platform from Carpegen and Systec". Amsterdam & Holzgerlingen. 2016-12-13
Bayer AG. (12/12/16). "Press Release: Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing". Leverkusen, et al.. 2016-12-12
Bayer AG. (12/12/16). "Press Release: Robert LaCaze to be Executive Vice President of New Oncology Strategic Business Unit at Pharmaceuticals Division of Bayer". Leverkusen. 2016-12-12
MolMed S.p.A.. (12/12/16). "Press Release: MolMed Coordinates a CAR T-cell Immunotherapy Project Awarded a 5.9 million Euro Grant by the European Commission". Milan. 2016-12-12
Novartis AG. (12/12/16). "Press Release: Novartis Provides Update on Pegpleranib Phase III Clinical Trial Program in Patients with Neovascular Age-related Macular Degeneration (nAMD or wet AMD)". Basel. 2016-12-12
Curetis N.V.. (12/12/16). "Press Release: #investEU – Curetis Obtains EIB Debt Financing Totaling up to EUR 25 Million to Further Expand Its Diagnostic Platform". Amsterdam, Holzgerlingen & Luxembourg. 2016-12-12
Evotec AG. (12/9/16). "Press Release: Evotec and Forge Therapeutics Form Strategic »Superbug« Alliance". Hamburg. 2016-12-09
SGS S.A.. (12/9/16). "Press Release: SGS Opens New Agriculture and Food Testing Laboratory in South Korea". 2016-12-09
SGS S.A.. (12/9/16). "Press Release: SGS Acquires 70 Percent Stake in Biopremier, Portugal". 2016-12-09
Inflazome Ltd.. (9/12/16). "Press Release: Inflazome Closes Series A Financing". Dublin. 2016-12-09
Probiodrug AG. (12/8/16). "Press Release: Innovative Phase II Study Design of Glutaminylcyclase Inhibitor PQ912 in Early Alzheimer’s disease". Halle (Saale). 2016-12-08
Singulex, Inc.. (12/8/16). "Press Release: Singulex and Thermo Fisher Scientific Enter into License and Supply Agreement to Bring Next Generation Immunodiagnostics to Sepsis and SIRS Diagnostics". Alameda, CA. 2016-12-08
Merck KGaA. (12/8/16). "Press Release: Merck Appoints Thomas Möller as New Head of External Communications". Darmstadt. 2016-12-08
Numares AG. (12/8/16). "Press Release: Numares AG Opens Singapore Subsidiary to Expand Its Diagnostic System into Asia". Regensburg. 2016-12-08
Ayoxxa Biosystems GmbH. (12/7/16). "Press Release: Ayoxxa Appoints Permanent CEO". Cologne. 2016-12-07
TCR2 Therapeutics Inc.. (12/7/16). "Press Release: TCR2 Therapeutics Launches from Stealth Mode to Accelerate Development of Novel Cancer Immunotherapies. $44.5M Series A Financing Led by MPM Capital and F2 Ventures". Cambridge, MA. 2016-12-07
Nordic Nanovector ASA. (12/7/16). "Press Release: Nordic Nanovector – Private Placement Successfully Completed [Not for the United States of America, Canada, Japan or Australia]". Oslo. 2016-12-07
Bayer AG. (12/7/16). "Press Release: Boehringer Ingelheim Vetmedica, Inc. and Bayer Enter into Agreement for Purchase of U.S. Cydectin Product Portfolio". Shawnee, KS. 2016-12-07
AstraZeneca plc. (12/6/16). "Press Release: Tagrisso Demonstrates Superiority over Chemotherapy in EGFR T790M Mutation-positive Non-small Cell Lung Cancer". 2016-12-06
MorphoSys AG. (12/6/16). "Press Release: MorphoSys Presents Updated Clinical Results for Anti-CD38 Antibody MOR202 at ASH 2016". 2016-12-06
MorphoSys AG. (12/6/16). "Press Release: MorphoSys Presents Updated Clinical Data for Blood Cancer Candidate MOR208 in NHL and CLL at ASH 2016 Conference". 2016-12-06
Affimed N.V.. (12/6/16). "Press Release: Affimed Presents New Preclinical Data on Bi- and Trispecific Immune Cell Engagers at ASH". Heidelberg. 2016-12-06
Merck KGaA. (12/6/16). "Press Release: Merck’s Consumer Health Business Drives Consumer-centric, Purposeful Innovation". Darmstadt. 2016-12-06
AstraZeneca plc. (12/5/16). "Press Release: AstraZeneca Completes Agreement With Cilag GmbH International for Rights to Rhinocort Aqua Outside the US". 2016-12-05
Novimmune S.A.. (12/5/16). "Press Release: Novimmune Grants Genentech an Exclusive Option to License NI-0101, its anti-TLR4 Monoclonal Antibody for the Treatment of Rheumatoid Arthritis". Geneva. 2016-12-05
Bayer AG. (12/5/16). "Press Release: Bayer and FaunaPhotonics Form Research Collaboration to Develop Sensor Technology for Improved Monitoring of Insect Pests". Monheim. 2016-12-05
Merck KGaA. (12/5/16). "Press Release: Merck to Provide Provantage End-to-End Services to Acticor Biotech SAS". Darmstadt. 2016-12-05
InGeneron Inc.. (12/5/16). "Press Release: German Accelerator Life Sciences. InGeneron Establishes Presence in Cambridge, MA and Initiates Collaboration with German Accelerator Life Sciences". Cambridge, MA & Berlin. 2016-12-05
Biomunex Pharmaceuticals SASU. (12/5/16). "Press Release: Biomunex Appoints Dr. Sebastian Amigorena and Dr. Dragan Grabulovski as Key Scientific and Strategic Advisors". Paris. 2016-12-05
Novartis AG. (12/3/16). "Press Release: Novartis SEG101 (Crizanlizumab, formerly SelG1) Significantly Reduces Frequency of Sickle Cell Pain Crises in Phase II Study". Basel. 2016-12-03
Bruker Corporation. (12/2/16). "Press Release: Bruker Announces Corporate Partnership with International Phenome Centre Network (IPCN) for NMR Technologies and SOPs". Billerica, MA. 2016-12-02
Apeptico Forschung und Entwicklung GmbH. (12/2/16). "Press Release: Apeptico and Mediolanum Sign a Research and Development Cooperation and License Agreement for Apeptico’s Therapeutic Peptide Solnatide". Vienna & Milano. 2016-12-02
Bellevue Group AG. (12/2/16). "Press Release: Successful Launch of BB Healthcare Trust plc on the London Stock Exchange – Initial Issue Volume GBP 150 Million [Not for US]". 2016-12-02
Merck KGaA. (12/2/16). "Press Release: Merck Introduces Milliplex High Sensitivity Panel for Faster, More Economical Cytokine Assays". Darmstadt. 2016-12-02
Merck KGaA. (12/2/16). "Press Release: Merck Launches Parteck MXP Excipient for Increased Solubility". Darmstadt. 2016-12-02
Valneva S.E.. (12/1/16). "Press Release: Leading Healthcare Investor MVM Life Science Partners Acquires 7.5% Shareholding in Valneva". Lyon. 2016-12-01
Pieris Pharmaceuticals, Inc.. (12/1/16). "Press Release: Pieris Pharmaceuticals Appoints Claude Knopf as Chief Business Officer". Boston, MA. 2016-12-01
AiCuris Anti-infective Cures GmbH. (12/1/16). "Press Release: AiCuris Announces Start of LipP 1 – First Subject Enrolled in the Clinical Phase 2 Trial with Topical Pritelivir for the Treatment of recurrent Labial Herpes". Wuppertal. 2016-12-01
Merck KGaA. (12/1/16). "Press Release: Merck Expands Distribution Agreement with Roche". Darmstadt. 2016-12-01
Coulter Partners. (12/1/16). "Press Release: Coulter Partners Places Chief Financial Officer for Medigene AG". 2016-12-01
Zedira GmbH. (11/30/16). "Press Release: Zedira Receives Funding by the German Government for the Development of Transglutaminase Inhibitors for the Treatment of Diabetic Nephropathy". Darmstadt. 2016-11-30
next pagenext page 1 2 3 ... 24 25 26 ... 96 97 98  next pagenext page


Picture [LSUS] – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

» top